| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials.
|
Wien Med Wochenschr
|
2010
|
0.99
|
|
2
|
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial.
|
Int Clin Psychopharmacol
|
2010
|
0.96
|
|
3
|
Drug cocktail interaction study on the effect of the orally administered lavender oil preparation silexan on cytochrome P450 enzymes in healthy volunteers.
|
Drug Metab Dispos
|
2013
|
0.81
|
|
4
|
Efficacy and safety of a combination of Sabal and Urtica extract in lower urinary tract symptoms--long-term follow-up of a placebo-controlled, double-blind, multicenter trial.
|
Int Urol Nephrol
|
2007
|
0.81
|
|
5
|
Efficacy and safety of a combination of sabal and urtica extract in lower urinary tract symptoms. A randomized, double-blind study versus tamsulosin.
|
Arzneimittelforschung
|
2006
|
0.80
|
|
6
|
Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies.
|
World J Urol
|
2014
|
0.75
|
|
7
|
No interacting influence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol/levonorgestrel combination.
|
Drugs R D
|
2014
|
0.75
|
|
8
|
Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set.
|
Int Clin Psychopharmacol
|
2017
|
0.75
|
|
9
|
Long-term efficacy and safety of PRO 160/120 (a combination of sabal and urtica extract) in patients with lower urinary tract symptoms (LUTS).
|
Phytomedicine
|
2003
|
0.75
|